NHGRI launches a new strategic plan to identify areas in genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Clinicians can be so focused on fixing problems and saving lives that they often avoid delivering news of a poor prognosis.
The number of people who have had their DNA analyzed with direct-to-consumer tests more than doubled during 2017, and now exceeds 12 million according to industry estimates.
New findings point to a technique that uses specially designed nanoparticles and near-infrared laser treatment to cause cancer cells to lose their multidrug resistance capabilities for days at a time.
A protein found in asparagus and other everyday foods has been linked to the spread of breast cancer, scientists have discovered.
A genomics startup co-founded by genetics pioneer George Church said yesterday that it seeks to lead the genomic data market by utilizing blockchain technology.
Reading the whole genetic blueprint of a fetus long before birth could become a routine procedure thanks to a new blood test.
A new consumer genomics test offers families immediately actionable information aimed at furthering the health of their youngest family members.
Researchers have discovered a molecular mechanism that may help to explain how viruses that cause chronic infections, such as HIV or hepatitis c virus, manage to outsmart their hosts’ immune systems.
For young children with cystic fibrosis, the lungs’ bacterial population changes in the first few years of life as respiratory infections and inflammation set in, new research suggests.
At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.